CFDE Data Portal | Search GAGE2A

	Label	Description
	GAGE2A Gene (Entity type)	ENSG00000189064 - G antigen 2A
	GAGE2A associations Collection (Entity type)	Associations for GAGE2A_associations
	GAGE2A associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135030 3 V 9 FLUDARABINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE212330 1 V 0 AZACITIDINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE101754 FXR1 knockdown NCI-H358 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE101754 FXR1 knockdown NCI-H358 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

GAGE2A

ENSG00000189064 - G antigen 2A

GAGE2A associations

Associations for GAGE2A_associations

GAGE2A associations.tsv

A file from IDG as part of the Harmonizome project

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 3 v 6 human dn

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human up

A Gene Set from LINCS

GSE135030 3 V 9 FLUDARABINE HUMAN DN

A Gene Set from LINCS

GSE212330 1 V 0 AZACITIDINE HUMAN UP

A Gene Set from LINCS

GSE101754 FXR1 knockdown NCI-H358 1 v 4 human up

A Gene Set from LINCS

GSE101754 FXR1 knockdown NCI-H358 5 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.